March 26, 2024

Impact Stories Highlight: Buddy’s Story 

“Hi, my name is Buddy. From my very first job, I’ve worked very hard. I retired, and three months later I started getting a rash on my skin. It was an ongoing battle for the next three years with several medications from my doctor.

In November 2021, some tumors appeared on my arms. I was diagnosed in December with Cutaneous T-Cell Lymphoma mycosis — Stage III. It was quite a shock to hear. I had to give up a part time job because of my condition. Going to doctors, hospitals and treatments created an unexpected financial burden. We reached out to the CLRA Patient Aid Program and were accepted from the beginning.

 I was calmed by the positive attitude and genuine interest of the CLRA. The CLRA has helped ease my financial costs and I am very grateful. 

The CLRA is committed to cancer research and cancer patient needs…a remarkable resource for future generations.”

According to the Mayo Clinic, Cutaneous T-Cell Lymphoma is a rare form of Non-Hodgkin Lymphoma that causes T cells to develop abnormalities that make them attack the skin. Treatments can include skin creams, light therapy, radiation therapy and systemic medications, such as chemotherapy.  Your contribution has the power to profoundly influence the lives of blood cancer patients, such as Buddy, ensuring they receive essential care while also advancing research towards a brighter, healthier tomorrow. Your support matters—please consider donating today!